
Volvick Derose
Examiner (ID: 2542, Phone: (571)272-6260 , Office: P/2115 )
| Most Active Art Unit | 2187 |
| Art Unit(s) | 2118, 2176, 2187, 2115 |
| Total Applications | 730 |
| Issued Applications | 638 |
| Pending Applications | 57 |
| Abandoned Applications | 62 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7202847
[patent_doc_number] => 20040086965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Casein peptide fragments with growth-influencing activity on cell cultures'
[patent_app_type] => new
[patent_app_number] => 10/380371
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1739
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380371
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380371 | Casein peptide fragments with growth-influencing activity on cell cultures | Oct 21, 2003 | Abandoned |
Array
(
[id] => 612798
[patent_doc_number] => 07148195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'LHRH antagonists having improved solubility properties'
[patent_app_type] => utility
[patent_app_number] => 10/671573
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6601
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10671573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/671573 | LHRH antagonists having improved solubility properties | Sep 28, 2003 | Issued |
Array
(
[id] => 7427993
[patent_doc_number] => 20040161769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Microbial oxidoreductase'
[patent_app_type] => new
[patent_app_number] => 10/655780
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12984
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655780 | Microbial oxidoreductase | Sep 4, 2003 | Abandoned |
Array
(
[id] => 7361711
[patent_doc_number] => 20040014670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Inhibitors of angiotensin converting enzyme'
[patent_app_type] => new
[patent_app_number] => 10/618644
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5580
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618644 | Inhibitors of angiotensin converting enzyme | Jul 14, 2003 | Abandoned |
Array
(
[id] => 769276
[patent_doc_number] => 07005419
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-28
[patent_title] => 'Methods for identifying inhibitors of GADD45 polypeptide activity and inhibitors of such activity'
[patent_app_type] => utility
[patent_app_number] => 10/600158
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 23388
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005419.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600158 | Methods for identifying inhibitors of GADD45 polypeptide activity and inhibitors of such activity | Jun 19, 2003 | Issued |
Array
(
[id] => 7459812
[patent_doc_number] => 20040052750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Compositions for prevention and alleviation of skin wrinkles'
[patent_app_type] => new
[patent_app_number] => 10/250596
[patent_app_country] => US
[patent_app_date] => 2003-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5636
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250596 | Compositions for prevention and alleviation of skin wrinkles | Jun 18, 2003 | Abandoned |
Array
(
[id] => 6629542
[patent_doc_number] => 20030211176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Sugar decomposition inhibitor, digestive enzyme activity inhibitor, insulin secretion controller, and healthy food and beverage'
[patent_app_type] => new
[patent_app_number] => 10/462334
[patent_app_country] => US
[patent_app_date] => 2003-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5788
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462334 | Sugar decomposition inhibitor, digestive enzyme activity inhibitor, insulin secretion controller, and healthy food and beverage | Jun 15, 2003 | Abandoned |
Array
(
[id] => 7329737
[patent_doc_number] => 20040254097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Compositions and methods for treatment of rosacea'
[patent_app_type] => new
[patent_app_number] => 10/457045
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7029
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457045 | Compositions and methods for treatment of rosacea | Jun 5, 2003 | Issued |
Array
(
[id] => 542876
[patent_doc_number] => 07169750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Methods to mobilize progenitor/stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/456942
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18823
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456942 | Methods to mobilize progenitor/stem cells | Jun 4, 2003 | Issued |
Array
(
[id] => 7605366
[patent_doc_number] => 07115563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Composition and its therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 10/447770
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7261
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447770 | Composition and its therapeutic use | May 28, 2003 | Issued |
Array
(
[id] => 7263597
[patent_doc_number] => 20040241741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Identification of proteins using a physical parameter and accurate amino acid content'
[patent_app_type] => new
[patent_app_number] => 10/446865
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5713
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10446865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/446865 | Identification of proteins using a physical parameter and accurate amino acid content | May 28, 2003 | Abandoned |
Array
(
[id] => 456625
[patent_doc_number] => 07244710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Treatment of ophthalmic infections using antimicrobial peptides'
[patent_app_type] => utility
[patent_app_number] => 10/442683
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6473
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10442683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/442683 | Treatment of ophthalmic infections using antimicrobial peptides | May 20, 2003 | Issued |
Array
(
[id] => 485136
[patent_doc_number] => 07217545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'Method for production of lactic acid'
[patent_app_type] => utility
[patent_app_number] => 10/438244
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438244 | Method for production of lactic acid | May 13, 2003 | Issued |
Array
(
[id] => 6770360
[patent_doc_number] => 20030216300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => ' Lectins as anti-fibrotic agents'
[patent_app_type] => new
[patent_app_number] => 10/435549
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2468
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10435549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/435549 | Lectins as anti-fibrotic agents | May 11, 2003 | Issued |
Array
(
[id] => 7297181
[patent_doc_number] => 20040214749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Compositions and methods for treatment of psoriasis'
[patent_app_type] => new
[patent_app_number] => 10/426239
[patent_app_country] => US
[patent_app_date] => 2003-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7646
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214749.pdf
[firstpage_image] =>[orig_patent_app_number] => 10426239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/426239 | Compositions and methods for treatment of psoriasis | Apr 27, 2003 | Issued |
Array
(
[id] => 6822076
[patent_doc_number] => 20030220237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/408558
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5245
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408558 | Pharmaceutical composition | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6835158
[patent_doc_number] => 20030162704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Method of treatment of parkison\'s disease with a protein extractable from mammalian organs'
[patent_app_type] => new
[patent_app_number] => 10/297670
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1595
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297670 | Method of treatment of parkison's disease with a protein extractable from mammalian organs | Mar 20, 2003 | Abandoned |
Array
(
[id] => 7126892
[patent_doc_number] => 20050058636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Medicament against thrombotic diseases'
[patent_app_type] => utility
[patent_app_number] => 10/387592
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2695
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10387592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/387592 | Medicament against thrombotic diseases | Mar 13, 2003 | Abandoned |
Array
(
[id] => 944138
[patent_doc_number] => 06967192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-22
[patent_title] => 'Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury'
[patent_app_type] => utility
[patent_app_number] => 10/384650
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4005
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/967/06967192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384650
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384650 | Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury | Mar 10, 2003 | Issued |
Array
(
[id] => 757362
[patent_doc_number] => 07015021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Method for making purified plasminogen activator-inhibitor type 1 (PAI-1) and purified PAI-1 made therefrom'
[patent_app_type] => utility
[patent_app_number] => 10/370828
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5370
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370828 | Method for making purified plasminogen activator-inhibitor type 1 (PAI-1) and purified PAI-1 made therefrom | Feb 19, 2003 | Issued |